Anzeige
Mehr »
Login
Samstag, 18.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Paukenschlag in den USA - diese Aktien könnten profitieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CM1C | ISIN: US75629V1044 | Ticker-Symbol:
NASDAQ
17.05.24
22:15 Uhr
9,420 US-Dollar
-0,090
-0,95 %
1-Jahres-Chart
RECURSION PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
RECURSION PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur RECURSION PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiRecursion Pharm Stock Sees Relative Strength Rating Rise To 846
MoRecursion Pharmaceuticals Stock Surges 10% As Nvidia-Powered Supercomputer Completion Sparks Investor Optimism6
MoRecursion Pharma gains on completing Nvidia-backed supercomputer BioHive-212
MoRecursion Pharmaceuticals: Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry104SALT LAKE CITY, May 13, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the completion...
► Artikel lesen
10.05.Demystifying Recursion Pharmaceuticals: Insights From 4 Analyst Reviews8
09.05.Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know22
09.05.RECURSION PHARMACEUTICALS, INC. - 10-Q, Quarterly Report3
06.05.Recursion (RXRX) to Report Q1 Earnings: What's in the Cards?11
02.05.(RXRX) - Analyzing Recursion Pharmaceuticals' Short Interest9
01.05.Recursion Pharmaceuticals: Recursion to Participate in Upcoming Investor Conferences6
26.04.Recursion Pharmaceuticals' Options Frenzy: What You Need to Know5
22.04.Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX42
17.04.Where Will Recursion Pharmaceuticals Be in 5 Years?15
16.04.Recursion Pharmaceuticals, Inc.: Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer625Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson & Johnson (J&J), will also join Recursion's Board of DirectorsSALT LAKE...
► Artikel lesen
16.04.RECURSION PHARMACEUTICALS, INC. - 8-K, Current Report7
10.04.Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.17
09.04.Analyst Scoreboard: 5 Ratings For Recursion Pharmaceuticals5
26.03.Recursion Pharmaceuticals: Recursion Publishes Annual Environmental, Social and Governance Report11
21.03.Recursion Pharmaceuticals director sells over $216k in company stock12
11.03.Recursion Pharmaceuticals, Inc.: Recursion Announces Plans to Open New Office in London456Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the...
► Artikel lesen
Seite:  Weiter >>
72 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
9,2,1